In this podcast, we dive deep into some of the most exciting advances in bladder cancer research that were presented at the 2023 ASCO Genitourinary Cancers congress. We will hear from Kyle Rose, MD, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, Robert Huddart, PhD, FRCR, MRCP, MBBS, The Royal Marsden Hospital and The Institute of Cancer Research, London, UK, Aristotelis Bamias, MD, National and Kapodistrian University of Athens, Athens, Greece, and Andrea Necchi, MD, Vita-Salute San Raffaele University and IRCCS San Raffaele Hospital and Scientific Institute, Milan, Italy. We’ll be discussing some of the most highly anticipated clinical trials that were presented at the conference, including IMvigor130 and KEYNOTE-057. We’ll also explore the use of circulating cell-free DNA to detect minimal residual disease, as well as the potential of adaptive image-guided radiotherapy. Join us as we explore these hot topics in bladder cancer research and hear from the experts themselves about what these developments mean for the future of bladder cancer treatment.

This podcast recording took place at the ASCO GU Cancers Symposium 2023 in San Francisco, CA.